Researchers create an effective RNA vaccine for malaria

Tech similar to COVID-19 mRNA vaccines might prevent one of the world's deadliest diseases

The Moderna mRNA vaccine works against newly emerged COVID-19 mutants

Mutants like B.1.1.7 and B.1.351 carrying changes in the virus spike protein appear to help the virus spread, but not to evade currently available vaccines

Blue gloved hand holding a glass vial

How the COVID-19 vaccine is distributed determines how the pandemic will end

National health care systems will make things more organized, but the US is still finding its footing

Empathy is key to overcoming COVID-19 vaccine hesitancy

COVID-19 vaccines are an enormous feat. Their use will hinge on explaining how it was done

How is the COVID-19 mRNA vaccine delivered to cells?

RNA is fragile, and the bloodstream a hostile place for foreign objects. How does the vaccine actually get where it needs to go?

A version of this article originally appeared on Undark

How should a COVID-19 vaccine be distributed?

With Pfizer and Moderna vaccines proving effective, how should a population get vaccinated?

How does Pfizer’s "90% effective" COVID-19 vaccine work?

Pfizer made a big news splash, but is their mRNA vaccine a silver bullet?

A virus-like COVID-19 vaccine is being grown in tobacco plants

The "virus-like particle" produced by the Canadian company Medicago is the only vaccine in clinical trials made in plants

Don't bank on herd immunity to save us from COVID-19

The best way forward is to use quality research to shape policy

What are the advantages of an mRNA vaccine for COVID-19?

They're easier to manufacture than traditional vaccines, but scientifically their history is checkered

Meet Lady Mary Montagu, who brought smallpox inoculation to England

This poet and essayist likely saved many lives from this deadly, disfiguring disease

Haven't heard of RNA therapy yet? You will

After a decade of painstaking progress​, the underdog is on the brink of treating a broad range of diseases

A version of this article originally appeared on NPR Scicommers

Can scientists learn from the stock market to eradicate HIV?

HIV is tricky to fight because the virus changes so much. That reminded researchers of something else that fluctuates frequently.